Topic: SANOFI
122 results were found.
Sanofi to settle thousands of Zantac cancer lawsuits - April 4, 2024
Sanofi appoints François-Xavier Roger as CFO - February 1, 2024
Sanofi Q4 income 555 million euros - February 1, 2024
Sanofi to acquire Inhibrx in $2.2bn deal - January 23, 2024
AstraZeneca, Sanofi's RSV treatment approved in China - January 2, 2024
Sanofi announces plans to spin off consumer arm - October 27, 2023
Sanofi collaborates with Janssen on vaccine for extraintestinal pathogenic E. coli - October 6, 2023
Sanofi Q1 income up 8.7% - April 27, 2023
Sanofi to acquire Provention Bio for $2.9 billion - March 13, 2023
Sanofi Q4 profit up 29.1 percent - February 3, 2023
AstraZeneca, Sanofi BLA for nirsevimab for respiratory syncytial virus accepted by FDA - January 6, 2023
Sanofi Pasteur COVID-19 vaccine authorised by UK’s independent medicines regulator - December 21, 2022
Sanofi Q3 operating income up 26.5 percent - October 28, 2022
Sanofi Q2 operating income rose 21.5% - July 28, 2022
Sanofi Q1 profit climbs 28.3 percent - April 28, 2022
Sanofi Q4 profit 1.13 billion - February 4, 2022
Sanofi and Exscientia in deal worth up to $5.2 billion - January 7, 2022
GSK, Sanofi COVID jab booster shows strong immune response - December 15, 2021
Sanofi announces positive Phase 1/2 study interim results for its first mRNA-based vaccine candidate - September 28, 2021
Sanofi to acquire Kadmon in $1.9 billion deal - September 8, 2021
Sanofi to acquire Translate Bio in $3.2 billion deal - August 3, 2021
Sanofi Q2 sales up 6.5% - July 29, 2021
Sanofi launches dedicated vaccines mRNA Center of Excellence - June 29, 2021
Sanofi and GlaxoSmithKline COVID-19 vaccine sees up to 100% efficacy - May 17, 2021
Sanofi Pasteur members poised to increase Canada’s vaccine production - May 13, 2021
Sanofi Q1 net income 1.57 billion euros - April 29, 2021
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate - March 12, 2021
Hawaii AG: Bristol Myers Squibb and Sanofi ordered to pay $834m in Plavix case - February 19, 2021
Sanofi Q4 business EPS Up 9.8% at CER - February 5, 2021
Sanofi to provide support to BioNTech in manufacturing their COVID-19 vaccine - January 27, 2021
Sanofi buys immunotherapy firm Kymab for up to $1.45 bln - January 11, 2021
Russia's Sputnik V developers ready to share technology with Sanofi and GSK - December 11, 2020
Sanofi, GSK announce delay in coronavirus vaccine until end of 2021 - December 11, 2020
Sanofi and GSK sign agreements with Canada to supply up to 72 million doses of coronavirus vaccine - September 23, 2020
Sanofi: Future coronavirus vaccine seen below 10 euros - September 5, 2020
Sanofi says Kevzara drug fails as possible coronavirus treatment - September 1, 2020
Sanofi to acquire Principia Biopharma for $3.7 billion - August 17, 2020
Sanofi charged with manslaughter by French court - August 3, 2020
GSK and Sanofi in talks to supply 300m vaccine doses to EU - August 3, 2020
EU concludes talks with Sanofi to secure 300 mln doses of coronavirus vaccine - August 1, 2020
Sanofi and GSK agree with UK government to supply more than 50 million doses of coronaviris vaccine - July 29, 2020
Sanofi says coronavirus vaccine will be available to all - May 15, 2020
France to Sanofi: It is unacceptable for vaccine to go to U.S. first - May 14, 2020
Sanofi: U.S. gave money, U.S. will get coronavirus vaccine first - May 13, 2020
Arcadia Consumer Healthcare acquires Kaopectate from Sanofi - March 21, 2020
Sanofi U.S. reaches $11.85 million settlement to resolve patient assistance allegations - February 29, 2020
Sanofi Q4 business profit rises 18.4% - February 6, 2020
Sanofi investigated over epilepsy drug linked to birth defects - February 4, 2020
Sanofi to acquire Synthorx for $2.5 billion - December 9, 2019
Sanofi opens new £37 million HQ in UK - October 12, 2019
Sanofi Q2 business net income rises - July 29, 2019
Sanofi appoints Paul Hudson as chief executive officer - June 7, 2019
Philippines to charge Sanofi, health officials over dengue vaccination deaths - March 1, 2019
Sanofi Q4 profit doubles - February 7, 2019
Competition Bureau in Canada completes abuse of dominance of Celgene, Pfizer, Sanofi - December 21, 2018
Sanofi to transfer ADS from NYSE to Nasdaq - December 19, 2018
Sanofi plans 670 job cuts in France - December 6, 2018
Advent International completed acquisition of Zentiva from Sanofi - October 2, 2018
Sanofi charged with FCPA violations - September 5, 2018
Sanofi Q2 IFRS earnings per share fell 25.6 percent - July 31, 2018
Sanofi in talks to sell generics arm to Advent for $2.4 billion - April 17, 2018
Sanofi, Evotec in talks to create R&D platform - March 8, 2018
Sanofi Q4 net income down 83.7 percent - February 7, 2018
Sanofi tells Philippines no refund for used dengue vaccine - February 5, 2018
Sanofi buys Ablynx for $4.8 billion - January 29, 2018
Sanofi to acquire Bioverativ for $11.6 billion - January 22, 2018
Sanofi Pasteur agrees to refund $27.8 million to Philippines - January 17, 2018
Philippines wants money back from Sanofi for dengue vaccine - December 8, 2017
Sanofi Q3 profit down, net sales up - November 2, 2017
Sanofi Q2 profit down, sales up - July 31, 2017
Sanofi to buy vaccines biotech group Protein Sciences for $650m, maybe more - July 11, 2017
Sanofi Pasteur rejects affordable price for Zika vaccine funded by U.S. government - June 15, 2017
Sanofi Q1 profit soars on Merial disposal, higher sales - April 28, 2017
Sanofi Pasteur to pay $19.8m for drug overcharges to veterans - April 4, 2017
FTC settles charges in Boehringer Ingelheim-Sanofi deal - February 25, 2017
Ipsen to buy some products from Sanofi for 83 million euros - February 13, 2017
Sanofi Q4 IFRS net income increased 136.5% - February 8, 2017
Sanofi appoints Kathleen Tregoning to executive committee - January 30, 2017
Sanofi, Boehringer Ingelheim confirm closing of business swap - January 2, 2017
Boehringer Ingelheim to sell 5 products to continue with $13.5bn Sanofi deal - December 29, 2016
Sanofi sues Novo Nordisk over diabetes drugs in U.S. - December 27, 2016
Sanofi looking to spend $29.6 billion on Actelion - December 17, 2016
Johnson & Johnson steps back from Actelion, Sanofi reportedly in game - December 14, 2016
EC approves acquisition of Sanofi's animal business by Boehringer Ingelheim - November 10, 2016
Sanofi Q3 net income grew 2.8 percent to 1.674 billion - October 28, 2016
Sanofi names Alan Main as EVP consumer healthcare - October 3, 2016
Sanofi gets $43m from Health Department for Zika vaccine - September 26, 2016
Sanofi files U.S. suit against Merck over patents - September 19, 2016
Sanofi and Verily Life Sciences of Alphabet create diabetes JV - September 12, 2016
EC clears acquisition of Boehringer Ingelheim's business by Sanofi - August 5, 2016
Medivation to open its secret books to Sanofi - July 6, 2016
Sanofi starts action to remove all Medivation directors - June 1, 2016
Sanofi names new executive committee - May 25, 2016
Sanofi to Medivation: Talk to us or we'll replace your board - May 5, 2016
Medivation rejects Sanofi's $9.3 billion bid - April 29, 2016
Sanofi Q1 aggregate sales €8,543 million, down 1.9% - April 29, 2016
Sanofi makes $9.3bn takeover bid for Medivation - April 28, 2016
Sanofi Pasteur and Merck end their joint work on vaccines - March 8, 2016
Sanofi Q4 net profit fell 75% to 334 million euros - February 9, 2016
Sanofi names Muzammil Mansuri as EVP, strategy & business development - February 5, 2016
Sanofi and Boehringer will swap businesses - December 15, 2015
Sanofi Pasteur gets approval for first dengue vaccine - December 10, 2015
AstraZeneca and Sanofi to share chemical compounds - November 23, 2015
Sanofi and Hanmi Pharmaceutical in worldwide license agreement - November 6, 2015
Sanofi and BioNTech in multiyear exclusive agreement - November 4, 2015
Sanofi recalls all pen injectors for allergic reactions - October 29, 2015
Sanofi Q2 group sales increased 4.9% - July 31, 2015
Sanofi names Suresh Kumar new member of executive committee - May 27, 2015
Moderna appoints former head of Sanofi global oncology as CMO - March 17, 2015
Sanofi appoints Olivier Brandicourt as CEO - February 20, 2015
Sanofi Q4 sales €9,072 million - February 6, 2015
Sanofi removes Christopher Viehbacher as CEO - October 29, 2014
Sanofi India appoints N Rajaram as country head - April 17, 2014
Sanofi appoints two executive vice presidents - May 2, 2013
Fabienne Lecorvaisier to join Sanofi - March 11, 2013
Serge Montero VP, general manager of Sanofi Pasteur MSD, France - January 14, 2013
Gary J. Nabel to lead strategic development at Sanofi - January 7, 2013
Sanofi's global president Hanspeter Spek to retire - December 19, 2012
Sanofi appoints Gary J. Nabel as chief scientific officer - November 15, 2012
Paul Chew to head global affairs at Sanofi - October 1, 2012
Sanofi-aventis: Wayne F. Pisano to retire, Olivier Charmeil SVP vaccines - December 13, 2010
Change in Sanofi-aventis executive committee - May 3, 2010